SCHEMBL24569726

SCHEMBL24569726

CC(=O)Nc1ccc2ncnc(Nc3ccc(Oc4ccc5c(c4)ncn5C)c(C)c3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.53
ERBB2 P04626 12/20 0.53
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
LCK P06239 1/20 0.48
FECH P22830 2/20 0.45
CDK8 P49336 1/20 0.45
MAP2K5 Q13163 1/20 0.45
CDK19 Q9BWU1 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
RAF1 P04049 1/20 0.45
BRAF P15056 1/20 0.45
NQO2 P16083 1/20 0.45
MYH14 Q7Z406 1/20 0.45
RIPK3 Q9Y572 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12888324 0.91 ERBB2 (0.52) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL12888316 0.91 EGFR (0.52) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL12888225 0.90 EGFR (0.62) EGFRERBB2
SCHEMBL24167726 0.90 ERBB2 (0.53) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL12888153 0.90 ERBB2 (0.56) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL12872671 0.89 ERBB2 (0.53) EGFRERBB2FECHNQO2MYH14
SCHEMBL12888163 0.89 ERBB2 (0.50) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL12888313 0.88 ERBB2 (0.49) EGFRERBB2FECHCDK8MAP2K5
SCHEMBL12888198 0.88 ERBB2 (0.53) EGFRERBB2FECHNQO2MYH14
SCHEMBL25429034 0.88 ERBB2 (0.53) EGFRERBB2MAPTFECHCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140769-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed